Medicated Skin Care in Egypt
Egypt saw a high and increasing birth rate during the review period, with the birth rate rising from 25.5 births per 1,000 inhabitants in 2006 to 28.5 births by 2011. This fuelled strong growth in the potential consumer base for nappy (diaper) rash treatments. While the revolution in 2011 resulted in a slight drop in the birth rate in the year, it remained considerably higher than that seen at the start of the review period.
Euromonitor International's Medicated Skin Care in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Medicated Skin Care in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Amoun Pharmaceutical Industry Co in Consumer Health (egypt)
Strategic Direction
Key Facts
Summary 1 Amoun Pharmaceutical Industry Co: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Amoun Pharmaceutical Industry Co: Competitive Position 2011
Executive Summary
Growth Boosted by Emergent Mid-income Group
Sales Hindered by Legislative Environment and Limited Distribution
Price Controls and 2011 Revolution Also Impact Growth
Domestic Players Continue To Lead
Health-awareness To Drive Growth in Forecast Period
Key Trends and Developments
Lack of Differentiation Between Otc, Rx and Utc Sales
Strong Competition From Herbal/traditional Products
Internet Retailing Offers An Alternative To Chemists/pharmacies
Revolution Has Little Impact on Sales Thanks To Emerging Mid-income Group
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 3 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Amoun Pharmaceutical Industry Co in Consumer Health (egypt)
Strategic Direction
Key Facts
Summary 1 Amoun Pharmaceutical Industry Co: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Amoun Pharmaceutical Industry Co: Competitive Position 2011
Executive Summary
Growth Boosted by Emergent Mid-income Group
Sales Hindered by Legislative Environment and Limited Distribution
Price Controls and 2011 Revolution Also Impact Growth
Domestic Players Continue To Lead
Health-awareness To Drive Growth in Forecast Period
Key Trends and Developments
Lack of Differentiation Between Otc, Rx and Utc Sales
Strong Competition From Herbal/traditional Products
Internet Retailing Offers An Alternative To Chemists/pharmacies
Revolution Has Little Impact on Sales Thanks To Emerging Mid-income Group
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 3 Research Sources